|
|
|
| Recent Editorials/Articles |
|
|
|
Wednesday, February 20, 2008
SIRO Clinpharm Private Limited (SIRO), a clinical research organisation (CRO), is going to implement a new IT framework comprising Oracle's Life Sciences Applications (OLSA) and other Oracle applications running on Sun Microsystems' hardware platform.
efytimes - Click here to view details
The Mumbai-based Siro Clinpharm Pvt Ltd, one of the leading contract research organisations (CRO) in the country, is all set to expand its overseas presence by acquiring a company in the Europe, it is learnt.
Indian Biotech Observer - Click here to view details
The Mumbai-based Siro Clinpharm Pvt Ltd, one of the leading players in the Indian contract research industry, is planning to offer clinical trials for Indian pharmaceutical companies in overseas sites such as the US and Europe.
Pharmabiz - Click here to view details
Kotak Private Equity Group and Kotak Realty Fund are together looking at investing $300 million in firms in India by the end of this financial year, reports Nishita Saxena in Hyderabad. Our focus will be on infrastructure, domestic consumption & consumer spending plays besides global manufacturing opportunities.
The Economic Times - Click here to view details
The Indian CRO sector registered 70 percent growth in 2006-07 over the previous year's revenues of Rs 425 crore with exports dominating the sector.Datamonitor's R&D Strategies 2007 report points out that the drug developers have become increasingly dependent on CROs, which themselves have become increasingly globalized.
Click here to view details
US-based private equity firm and venture capitalist 3i Capital has picked up a strategic stake in Siro Clinpharm, one of the country's largest and oldest Clinical Trial and Research Organisations (CRO), in its largest-ever investment in the country.
The Hindustan Times - Click here to view details
|
|
|
|
